Latest Foreign Investment Review News

Mayne Pharma updates investors on the extended FIRB approval deadline and potential financing hurdles in its proposed acquisition by Cosette Pharmaceuticals.

Infomedia Ltd shareholders have overwhelmingly approved a scheme of arrangement for acquisition by TPG Capital, valuing the company at approximately AUD 651 million. The deal, supported by the board and an independent expert, is set to complete by early December 2025.

RPMGlobal shareholders are set to vote on Caterpillar’s $5.00 per share acquisition proposal following Federal Court approval to convene a Scheme Meeting. The Independent Expert deems the offer fair and reasonable, with the RPM Board unanimously backing the deal.

Infomedia Limited has secured Foreign Investment Review Board approval for its proposed acquisition by TPG Capital-backed McQueen BidCo, marking a key regulatory milestone. The Infomedia Board continues to recommend shareholder support ahead of upcoming votes.

Suzerain Investment Holdings Ltd has initiated an off-market takeover offer for all remaining shares in Entertainment Rewards Ltd at a significant premium, aiming to consolidate full ownership and potentially delist the company from the ASX.

The Foreign Investment Review Board has extended its deadline for approving Mayne Pharma's acquisition by Cosette Pharmaceuticals, maintaining the current transaction timetable for now.

Mineral Resources Limited and POSCO Holdings have agreed to form a $1.2 billion joint venture for their lithium assets, marking a significant step in global lithium supply partnerships. The deal will strengthen MinRes’ balance sheet and deepen ties between Australia and Korea in critical minerals.

Global Uranium and Enrichment Limited has entered a new funding agreement with Summit Strategies LLC, raising an additional A$2.5 million through convertible notes to support its ongoing operations and merger obligations with Snow Lake Resources.

Mayne Pharma has received notice of Cosette Pharmaceuticals' intention to appeal a court ruling in their acquisition dispute, potentially delaying the proposed takeover. The legal saga continues as key approvals and hearings loom.

AGL Energy has agreed to divest 19.9% of its 20% stake in Tilt Renewables for $750 million, reinforcing its strategy to recycle capital and invest in flexible energy capacity while maintaining a strategic partnership.

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a regulatory delay as the Foreign Investment Review Board extends its approval deadline, pushing the court hearing to mid-November.

Mayne Pharma updates shareholders on the extended Foreign Investment Review Board approval deadline and the rescheduled court hearing for its acquisition scheme by Cosette Australia BidCo.